Prioritization of Therapy Options for a Patient With High Tumor Mutation Burden and Microsatellite Instability but No Clinical Benefit From Immunotherapy.

ABSTRACT:

SUBMITTER: Nelson RS 

PROVIDER: S-EPMC7446362 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature